Reaction
Chronic Graft Versus Host Disease In Lung reporting signals
As of the last recalculation, Chronic Graft Versus Host Disease In Lung appears in 167 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 246.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Thiotepa | 17 | 246.9 | 247.3 |
| Posaconazole Delayed-Release | 14 | 173.3 | 173.6 |
| Fludarabine Phosphate | 40 | 166.4 | 166.6 |
| Busulfan | 18 | 159.7 | 159.9 |
| Ruxolitinib | 56 | 146.0 | 146.1 |
| Posaconazole | 16 | 135.6 | 135.8 |
| Sirolimus | 13 | 130.3 | 130.5 |
| Imatinib | 11 | 83.1 | 83.2 |
| Micafungin Sodium | 5 | 75.7 | 75.8 |